Company profileSME (from the award notice)
Originalis B.V.
- Legal form
- B.V.
- Seat
- Amsterdam, Netherlands
Based on the notices and sources Inteliwert covers; not a complete record. Last checked 30 October 2026.
Identifiers
Not found in the indexed notices.
Track record in public tenders
Awards in the covered notices over the last 36 months, per CPV division.
| CPV division | Awards | Award value (excl. VAT) | Buyers | Repeat buyers | First award | Last award |
|---|---|---|---|---|---|---|
| 33 Medical equipments, pharmaceuticals and personal care products | 1 | €1 | 1 | 0 | 30 October 2026 | 30 October 2026 |
Awards
- Abschluss eines nicht-exklusiven Rabattvertrages gemäߧ 130c Abs. 1 SGB V zwischen der IKK classic und Abacus Medicine und Originalis B.V. zu BimzelxBuyer: IKK classic · Award value: €1 excl. VAT · Awarded: 30 October 2026 · CPV 33600000
Certifications and prequalification
No certification or prequalification found in the covered sources.
A certification missing here is unknown, not absent.
Website and LinkedIn
Not found in the indexed notices.
Open tenders that might fit
Possible match based on public information
Companies Inteliwert knows from its sources, not the whole market. Inteliwert does not judge eligibility, fit or chances.
-
OpenTenderSME (from the award notice)New to public tenders
Open-House-Rabattverträge 2026-18
Reasons
- Won a contract in CPV group 336 (2026-10-30) Evidence · checked 4 Nov 2026
- Seat outside the country of performance Evidence · checked 4 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 4 Nov 2026
Last checked 28 Oct 2026, 06:30 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)New to public tenders
Open-House-Rabattverträge 2026-19 Adalimumab
Reasons
- Won a contract in CPV group 336 (2026-10-30) Evidence · checked 5 Nov 2026
- Seat outside the country of performance Evidence · checked 5 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 5 Nov 2026
Last checked 4 Nov 2026, 16:10 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)New to public tenders
Dynamisches Beschaffungssystem Arzneimittel
Reasons
- Won a contract in CPV group 336 (2026-10-30) Evidence · checked 5 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 5 Nov 2026
Last checked 4 Nov 2026, 16:10 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)New to public tenders
Arzneimittel- Rahmenrabattverträge nach §130a Absatz 8 SGB V
Reasons
- Won a contract in CPV group 336 (2026-10-30) Evidence · checked 4 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 4 Nov 2026
Last checked 26 Oct 2026, 15:14 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)New to public tenders
1/DLII6/VM155 - RV Arzneimittel, divers
Reasons
- Won a contract in CPV group 336 (2026-10-30) Evidence · checked 4 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 4 Nov 2026
Last checked 4 Nov 2026, 16:10 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)New to public tenders
Generikaausschreibung
Reasons
- Won a contract in CPV group 336 (2026-10-30) Evidence · checked 5 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 5 Nov 2026
Last checked 4 Nov 2026, 16:10 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)New to public tenders
Abschlusses eines nicht-exkl. Rabattvertrags nach § 130a Absatz 8 bzw. 130c Absatz 1 SGB V für die Zeit vom 01.12.2026 bis zum i.d.R. 30.11.2028
Reasons
- Won a contract in CPV group 336 (2026-10-30) Evidence · checked 4 Nov 2026
- Seat outside the country of performance Evidence · checked 4 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 4 Nov 2026
Last checked 26 Oct 2026, 15:28 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)New to public tenders
Belieferung der radiologisch tätigen Vertragsärzte in den Bereichen der KV Westfalen-Lippe und der KV Nordrhein mit Kontrastmitteln - Fachlos A
Reasons
- Won a contract in CPV group 336 (2026-10-30) Evidence · checked 4 Nov 2026
- Seat outside the country of performance Evidence · checked 4 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 4 Nov 2026
Last checked 26 Oct 2026, 15:14 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)New to public tenders
Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Certolizumab pegol (ATC-Code nach WHO: L04AB05)
Reasons
- Won a contract in CPV group 336 (2026-10-30) Evidence · checked 4 Nov 2026
- Seat outside the country of performance Evidence · checked 4 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 4 Nov 2026
Last checked 26 Oct 2026, 15:21 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)New to public tenders
Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V ab dem 15.12.2026
Reasons
- Won a contract in CPV group 336 (2026-10-30) Evidence · checked 4 Nov 2026
- Seat outside the country of performance Evidence · checked 4 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 4 Nov 2026
Last checked 26 Oct 2026, 15:28 (UTC+01:00)Official notice
Is this your company?
Send corrections, or ask us to remove the profile, to hello@inteliwert.com. You can also ask that the company never be tagged on LinkedIn.
About this profile
Each fact on this page shows its source: a public notice, an open-data register (GLEIF, Wikidata) or the company’s own website. Inteliwert does not rate companies and does not judge eligibility, fit or chances.
Based on the notices and sources Inteliwert covers; not a complete record.
Last checked 30 October 2026.